Caliper Life Sciences, Inc. (CALP) Tops Q3 EPS by 4c, Sales Top Expectations
Tweet
Share
E-mailGet Alerts CALP Hot Sheet
Join SI Premium – FREE
Caliper Life Sciences, Inc. (NASDAQ: CALP) reported Q3 EPS of $0.03, $0.04 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $35.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
